Variation_Name | GeneID | GeneSymbol | ClinicalSignificance | dbSNP | RCVaccession | TestedInGTR | PhenotypeIDs | Chromosome | Start | Stop | HGVS_c | HGVS_p | HGVS_g | OtherIDs | Disease_ClinVar | Disease_hgmd | NM_006516.2(SLC2A1):c.940G>A (p.Gly314Ser) | 6513 | SLC2A1 | Pathogenic | 121909739 | RCV000179919; RCV000017493; RCV000179920; RCV000153967; | N | MedGen:C1842534,OMIM:612126,ORPHA:98811; MedGen:C1847501,OMIM:606777,ORPHA:71277; MedGen:C3553859,OMIM:614847; MedGen:CN221809 | 1 | 43394913 | 43394913 | NM_006516.2:c.940G>A | NP_006507.2:p.Gly314Ser | NC_000001.10:g.43394913C>T | HGMD:CM081811,OMIM Allelic Variant:138140.0009 | C3553859 614847 Epilepsy, idiopathic generalized, susceptibility to, 12; C1847501 606777 Glucose transporter type 1 deficiency syndrome; C1842534 612126 GLUT1 deficiency syndrome 2; CN221809 not provided | | |
NM_006516.2(SLC2A1):c.938C>T (p.Ser313Phe) | 6513 | SLC2A1 | Likely pathogenic | 794727870 | RCV000209836; | N | MedGen:C1842534,OMIM:612126,ORPHA:98811 | 1 | 43394915 | 43394915 | NM_006516.2:c.938C>T | NP_006507.2:p.Ser313Phe | | - | C1842534 612126 GLUT1 deficiency syndrome 2 | | |
NM_006516.2(SLC2A1):c.823G>A (p.Ala275Thr) | 6513 | SLC2A1 | Pathogenic | 121909740 | RCV000147534; RCV000017494; RCV000189361; | N | MedGen:C1842534,OMIM:612126,ORPHA:98811; MedGen:C1847501,OMIM:606777,ORPHA:71277; MedGen:CN221809 | 1 | 43395308 | 43395308 | NM_006516.2:c.823G>A | NP_006507.2:p.Ala275Thr | NC_000001.10:g.43395308C>T | OMIM Allelic Variant:138140.0010 | C1847501 606777 Glucose transporter type 1 deficiency syndrome; C1842534 612126 GLUT1 deficiency syndrome 2; CN221809 not provided | | |
NM_006516.2(SLC2A1):c.517-1G>C | 6513 | SLC2A1 | Uncertain significance | 869312673 | RCV000209843; | N | MedGen:C1842534,OMIM:612126,ORPHA:98811 | 1 | 43395707 | 43395707 | NM_006516.2:c.517-1G>C | | NC_000001.10:g.43395707C>G | - | C1842534 612126 GLUT1 deficiency syndrome 2 | | |
NM_006516.2(SLC2A1):c.376C>T (p.Arg126Cys) | 6513 | SLC2A1 | Pathogenic | 80359818 | RCV000017498; RCV000030838; RCV000030839; RCV000178276; RCV000081431; | N | Gene:1433,MedGen:C1832855,OMIM:601042,ORPHA:53583; MedGen:C1842534,OMIM:612126,ORPHA:98811; MedGen:C1847501,OMIM:606777,ORPHA:71277; MedGen:C3553859,OMIM:614847; MedGen:CN221809 | 1 | 43396437 | 43396437 | NM_006516.2:c.376C>T | NP_006507.2:p.Arg126Cys | NC_000001.10:g.43396437G>A | HGMD:CM044064,OMIM Allelic Variant:138140.0014 | C1832855 601042 Choreoathetosis/spasticity, episodic; C3553859 614847 Epilepsy, idiopathic generalized, susceptibility to, 12; C1847501 606777 Glucose transporter type 1 deficiency syndrome; C1842534 612126 GLUT1 deficiency syndrome 2; CN221809 not prov | | |
NM_006516.2(SLC2A1):c.283_284delTCinsAT (p.Ser95Ile) | 6513 | SLC2A1 | Pathogenic | 267607060 | RCV000017496; | N | MedGen:C1842534,OMIM:612126,ORPHA:98811 | 1 | 43396529 | 43396530 | NM_006516.2:c.283_284delTCinsAT | NP_006507.2:p.Ser95Ile | NC_000001.10:g.43396529_43396530delGAinsAT | OMIM Allelic Variant:138140.0012 | C1842534 612126 GLUT1 deficiency syndrome 2 | | |
NM_006516.2(SLC2A1):c.277C>T (p.Arg93Trp) | 6513 | SLC2A1 | Pathogenic | 267607061 | RCV000030922; | N | MedGen:C1842534,OMIM:612126,ORPHA:98811 | 1 | 43396536 | 43396536 | NM_006516.2:c.277C>T | NP_006507.2:p.Arg93Trp | NC_000001.10:g.43396536G>A | OMIM Allelic Variant:138140.0013 | C1842534 612126 GLUT1 deficiency syndrome 2 | | |
NM_006516.2(SLC2A1):c.274C>T (p.Arg92Trp) | 6513 | SLC2A1 | Pathogenic | 202060209 | RCV000017499; | N | MedGen:C1842534,OMIM:612126,ORPHA:98811 | 1 | 43396718 | 43396718 | NM_006516.2:c.274C>T | NP_006507.2:p.Arg92Trp | NC_000001.10:g.43396718G>A,NC_000001.10:g.43396718G>T | OMIM Allelic Variant:138140.0015 | C1842534 612126 GLUT1 deficiency syndrome 2 | | |
NM_006516.2(SLC2A1):c.101A>T (p.Asn34Ile) | 6513 | SLC2A1 | Pathogenic | 80359812 | RCV000030921; | N | MedGen:C1842534,OMIM:612126,ORPHA:98811 | 1 | 43408910 | 43408910 | NM_006516.2:c.101A>T | NP_006507.2:p.Asn34Ile | NC_000001.10:g.43408910T>A | OMIM Allelic Variant:138140.0011 | C1842534 612126 GLUT1 deficiency syndrome 2 | | |